Postradiation high-grade myofibroblastic sarcoma of the prostate - A rare entity of prostatic tumors - Responding to liposomal doxorubicin

Onkologie

Volumn 25, Issue 6, 2002, Pages 558-561

  Joerger, M ^b   Oehlschlegel, C ^b   Cerny, T ^b   Gillessen, Silke ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b NONE

Author keywords

Carcinosarcoma; Liposomal doxorubicin; Myofibroblastic sarcoma; Postradiation sarcoma; Prostatic irradiation; Prostatic sarcoma

Indexed keywords

DOXORUBICIN; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADENOSARCOMA; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPIRATION BIOPSY; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG ACTIVITY; DRUG FORMULATION; DRUG RESPONSE; DRUG SAFETY; HAND FOOT SYNDROME; HUMAN; IRRADIATION; LONG TERM CARE; MALE; METASTASIS; MYOFIBROBLAST; ORCHIECTOMY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROSTATECTOMY; RECURRENT DISEASE; REMISSION; THORAX RADIOGRAPHY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DOXORUBICIN; FOLLOW-UP STUDIES; HUMANS; LIPOSOMES; MALE; MYOSARCOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; ORCHIECTOMY; PROSTATE; PROSTATIC NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0036986292     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068628     Document Type: Article

References (23)

1. Varghese SL, Grossfeld GD: The prostatic gland: Malignancies other than adenocarcinomas. Radiol Clin North Am 2000;38:179-202.
2. Murray EM, Werner D, Greeff EA, Taylor DA: Po-stradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys 1999;45:951-961.
3. Canfield SE, Gans WH, Unger P, Hall SJ: Postradiation prostatic sarcoma: De novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma? Tech Urol 2001;7:294-295.
4. Mentzel T, Dry S, Katenkamp D, Fletcher C: Low-grade myofibroblastic sarcoma. Am J Surg Pathol 1998;22:1228-1238.
5. Lagace R, Seemayer TA, Gabbiani G, Schürch W: Myofibroblastic sarcoma. Am J Surg Pathol 1999; 23:1432-1435.
6. Blackledge G, van Oosterom A, Mouridsen H, Steward WP, Buesa J, Thomas D, Sylvester R, Rouesse J: Doxorubicin in relapsed soft tissue sarcoma: Justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study. Eur J Cancer 1990;26:139-141.
7. Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q, le Cesne A, van Oosterom AT, Clemons MJ, Kamby C, Hermans C, Whittaker J, di Paola ED, Verweij J, Nielsen S: Randomised phase II trial of pegylated liposomal doxorubicin (Doxil/Caelix) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: A study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2001;37:870-877.
8. Gabizon A, Uziely B, Lotem M: Doxil in patients with pretreated metastatic breast cancer: A dose-schedule finding study with pharmacokinetics. Proc Am Soc Clin Oncol 1997;16;516 (abstr).
9. Gabizon AA: Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest 2001;19:424-436.
10. Scully JM, Uno JM, McIntyre M, Mosely S: Radiation-induced prostatic sarcoma: A case report. J Urol 1990;144:746-748.
11. Dundore PA, Cheville JC, Nascimento AG, Farrow GM, Bostwick DG: Carcinosarcoma of the prostate. Report of 21 cases. Cancer 1995;76:1035-1042.
12. Greiner RH, Blattmann HJ, Thum P, Coray A, Crawford JF, Kann RH, Munkel G, Pedroni E, von Essen CF, Zimmermann A: Dynamic pion irradiation of unresectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1989;17:1077-1083.
13. Greiner R, Blattmann H, Thum P, Bosiger P, Coray A, Kann R, Lahtinen T, Reinhardt H, von Essen CF, Zimmermann A: Anaplastic astrocytoma and glioblastoma: Pion irradiation with the dynamic conformation technique at the Swiss Institute for Nuclear Research (SIN). Radiother Oncol 1990;17:37-46.
14. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I: Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-1105.
15. Beddouch A, Ameur A, al Bouzidi A, Touiti D, Benomar S, Oukheira H: Undifferentiated sarcoma of the prostate: Report of a case. Ann Urol (Paris) 2000;34:49-52.
16. Narayana AS, Loening S, Weimar GW, Culp DA: Sarcoma of the bladder and prostate. J Urol 1978;119:72-76.
17. Quinlan DM, Stutzman RE, Peters CA, Walsh PC: Unilateral nerve-sparing radical prostatectomy and hemicystectomy in management of prostate sarcoma. Urology 1993;41:308-310.
18. Toma S, Tucci A, Villani G, Carteni G, Spadini N, Palumbo R: Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: A phase II study of the Italian Sarcoma Group (ISG). Anti-cancer Res 2000;20:485-491.
19. Chidiac T, Budd GT, Pelley R, Sandstrom K, McLain D, Elson P, Crownover R, Marks K, Muschler G, Joyce M, Zehr R, Bukowski R: Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas. Invest New Drugs 2000;18:253-259.
20. Garcia AA, Kempf RA, Rogers M, Muggia FM: A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas. Ann Oncol 1998;9:1131-1133.
21. Vaage J, Barbera-Guillem E, Abra R, Huang A, Working P: Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer 1994;73:1478-1484.
22. Vaage J, Donovan D, Uster P, Working P: Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. Br J Cancer 1997;75:482-486.
23. Huber A, Lyass O, Pode D, Gabizon A: Doxil (Caelyx): An exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer. Anti Cancer Drugs 2000;11:123-127.